What can we learn from Covid-19 pandemic’s impact on human behaviour? The case of France’s lockdown | Humanities and Social Sciences Communications
Covid19-Sources
Brazil's COVID-19 daily deaths total surges
Pennsylvania and L.A. Move Up Dates for Vaccine Eligibility - The New York Times
The impact of the COVID-19 pandemic on influenza, respiratory syncytial virus, and other seasonal respiratory virus circulation in Canada | medRxiv
Indoor Air Changes and Potential Implications for SARS-CoV-2 Transmission | Environmental Health | JAMA | JAMA Network
A guideline to limit indoor airborne transmission of COVID-19 | PNAS
Some experts fear next-generation Covid vaccines may be worse
Synapsen: Kinderseelen in der Pandemie | NDR.de - Nachrichten - NDR Info
The Novel Coronavirus Variants and India's Uncertain Future - The Wire Science
How to Help Your Adolescent Think About the Last Year - The New York Times
Gesundheitsämter und COVID-19: Maßgeschneiderte Eindämmungsinterventionen
Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study - The Lancet Infectious Diseases
Increased household secondary attacks rates with Variant of Concern SARS-CoV-2 index cases | medRxiv
Brazil's hospitals running out of sedatives as COVID-19 rages | Reuters
Coronakinderstudien „Co-Ki“: erste Ergebnisse eines deutschlandweiten Registers zur Mund-Nasen-Bedeckung (Maske) bei Kindern | SpringerLink
Ten scientific reasons in support of airborne transmission of SARS-CoV-2 - The Lancet
Risk of rare blood clotting higher for COVID-19 than for vaccines | University of Oxford
Risikogebiete Deutschland
Sauerstoffsättigung - O2S | Gesundheitsportal
(1) Sus Scrofa - ZeroCovid saves lives and livelihoods auf Twitter: "Dieser Artikel hätte meines Erachtens auf die Titelseite der Sonntagszeitung gehört. Hervorragend. https://t.co/weOQeP4y24" / Twitter
(10) Eric Feigl-Ding auf Twitter: "The most important vaccine in Latin America—SinoVac’s CoronaVac reports new trial results from Brazil 🇧🇷— Efficacy against symptomatic #COVID19–50.7%. Moderate & severe: 83.7% / 100%. Delayed 2nd dose no issue. Neut. titres lower in age>=60 against #P1.🧵 https://t.co/tMg6Kn8TAe https://t.co/XtHo9gnAzO" / Twitter
Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques | bioRxiv
Psychologie - Spätfolgen des Traumas - Wissen - SZ.de
Christian Fries auf Twitter: "Vorschlag für ein effektiveres (reaktiveres) Steuerinstrument im #Corona Management. (Request for Comments) 🔵 Maßnahmen sollten kombiniert an die Inzidenz und die Veränderung der Inzidenz gebunden werden. 1/16" / Twitter
Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial - The Lancet Respiratory Medicine
SARS-CoV-2 outbreak in a long-term care facility after vaccination with BNT162b2 | Clinical Infectious Diseases | Oxford Academic
Recovered not restored: Long-term health consequences after mild COVID-19 in non-hospitalized patients | medRxiv
RKI: Virusübertragung durch geimpfte Personen unwahrscheinlich
The "false-positive PCR" problem is not a problem - Virology Down Under